US StockDetailed Quotes

Provided by Tiger Fintech (Singapore) Pte. Ltd.

ENGENE HOLDINGS INC

4.00

+0.01000.25%

Post-market: 4.000.00000.00%16:05 EDT

Volume:71.68K

Turnover:287.49K

Market Cap:203.91M

PE:-2.59

High:4.39

Open:3.99

Low:3.90

Close:3.99

Loading ...

Overview Company News Filings

enGene reports inducement grants under NASDAQ listing rule

enGene Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)

enGene Holdings Is Maintained at Overweight by Morgan Stanley

enGene Holdings Price Target Maintained With a $25.00/Share by HC Wainwright & Co.

enGene Holdings Q1 2025 GAAP EPS $(0.48) Misses $(0.39) Estimate

enGene Holdings Inc Qtrly Loss per Share $0.48

THOMSON REUTERS

Press Release: enGene Reports First Quarter 2025 Financial Results and Provides Business Update

New Strong Buy Stocks for February 19th

Piper Sandler Initiates Coverage on enGene Holdings With Overweight Rating, $26 Price Target

MT Newswires Live

enGene Holdings Initiated at Overweight by Piper Sandler

enGene initiated with an Overweight at Piper Sandler

Buy Rating for enGene Holdings: Strategic Positioning and Growth Potential in NMIBC Market

enGene Holdings Inc : Piper Sandler Initiates Coverage With Overweight Rating; Price Target $26

THOMSON REUTERS

Sector Update: Health Care Stocks Decline Late Afternoon

MT Newswires Live

enGene Holdings Shares Fall After UBS Downgrade

MT Newswires Live

enGene Holdings Cut to Neutral From Buy by UBS

UBS Downgrades enGene Holdings to Neutral From Buy, Cuts Price Target to $7 From $34

MT Newswires Live

enGene Holdings Inc : UBS Cuts to Neutral From Buy

THOMSON REUTERS

enGene Reports Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)

THOMSON REUTERS

enGene Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/ENGN/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"ENGN","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"ENGN\",,,,,undefined,":{"symbol":"ENGN","market":"US","secType":"STK","nameCN":"ENGENE HOLDINGS INC","latestPrice":4,"timestamp":1745524800000,"preClose":3.99,"halted":0,"volume":71676,"hourTrading":{"tag":"盘后","latestPrice":4,"preClose":4,"latestTime":"16:05 EDT","volume":1,"amount":4,"timestamp":1745525108706},"delay":0,"floatShares":24461393,"shares":50977560,"eps":-1.543739,"marketStatus":"Closed","change":0.01,"latestTime":"04-24 16:00:00 EDT","open":3.99,"high":4.39,"low":3.9,"amount":287485.3484,"amplitude":0.122807,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-1.543739,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1745568000000},"marketStatusCode":5,"adr":0,"exchange":"NASDAQ","adjPreClose":3.99,"preHourTrading":{"tag":"盘前","latestPrice":4.12,"preClose":3.99,"latestTime":"09:25 EDT","volume":13,"amount":55.680001,"timestamp":1745501100034},"postHourTrading":{"tag":"盘后","latestPrice":4,"preClose":4,"latestTime":"16:05 EDT","volume":1,"amount":4,"timestamp":1745525108706},"volumeRatio":1.572021},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"ENGN\",,,,,undefined,":{"symbol":"ENGN","floatShares":24461393,"roa":"-25.75%","roe":"-44.21%","lyrEps":-1.459464,"volumeRatio":1.572021,"shares":50977560,"dividePrice":1.59238,"high":4.39,"amplitude":0.122807,"preClose":3.99,"low":3.9,"week52Low":3.5,"pbRate":"0.82","week52High":16.6189,"institutionHeld":0,"latestPrice":4,"eps":-1.543739,"divideRate":0.398095,"volume":71676,"delay":0,"ttmEps":-1.543739,"open":3.99,"prevYearClose":6.65,"prevWeekClose":4,"prevMonthClose":4.48,"prevQuarterClose":4.48,"fiveDayClose":3.96,"twentyDayClose":4.66,"sixtyDayClose":6.93},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"ENGN\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2524218206","title":"enGene reports inducement grants under NASDAQ listing rule","url":"https://stock-news.laohu8.com/highlight/detail?id=2524218206","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2524218206?lang=en_us&edition=fundamental","pubTime":"2025-04-04 20:12","pubTimestamp":1743768722,"startTime":"0","endTime":"0","summary":"enGene (ENGN) Holdings reported the grant of inducement equity awards to seven newly-hired employees, with a grant date of April 2, 2025. The induc...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/engene-reports-inducement-grants-under-nasdaq-listing-rule?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/engene-reports-inducement-grants-under-nasdaq-listing-rule?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU2210149790.SGD","BK4139","SQQQ","NDAQ",".IXIC","TQQQ","BK4588","QID","BK4585","USAW.SI","IE00B64PRP62.GBP","NVIW.SI","ENGN","USJW.SI","QLD","MNQmain","IE00BKPKM429.USD","TSYW.SI","LU2095319765.USD","PSQ","NQmain","LU2210150020.SGD","BK4112","IE00BGHQF748.EUR","IE00B3QW5Z07.USD"],"gpt_icon":0},{"id":"2524205095","title":"enGene Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)","url":"https://stock-news.laohu8.com/highlight/detail?id=2524205095","media":"Business Wire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2524205095?lang=en_us&edition=fundamental","pubTime":"2025-04-04 20:00","pubTimestamp":1743768000,"startTime":"0","endTime":"0","summary":"BOSTON & MONTREAL, April 04, 2025----enGene Holdings Inc. , a clinical-stage, non-viral genetic medicines company, today reported the grant of inducement equity awards to seven newly-hired employees, with a grant date of April 2, 2025. The inducement awards consist of a non-qualified stock options to purchase an aggregate 144,650 of the Company's common shares. The options each have an exercise price of $4.44 per share, which is equal to the closing price of the Company's common shares on April 2, 2025, the date of grant. Each stock option has a 10-year term and will vest over four years, with 25% of the underlying shares vesting on the one-year anniversary of the employee’s employment commencement date and the remainder vesting in equal amounts monthly for three years thereafter, subject to the employee’s continued service as an employee of, or other service provider to, the Company through the applicable vesting dates.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/engene-reports-inducement-grants-under-120000127.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4135","BK4139","ENGNW","ENGN","NDAQ","BK4588","LU2210149790.SGD","LU2210150020.SGD",".IXIC","BK4112","BCG","IE00BGHQF748.EUR","BK4585","IE00B64PRP62.GBP","IE00B3QW5Z07.USD","LU2095319765.USD","IE00BKPKM429.USD"],"gpt_icon":0},{"id":"2518740988","title":"enGene Holdings Is Maintained at Overweight by Morgan Stanley","url":"https://stock-news.laohu8.com/highlight/detail?id=2518740988","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2518740988?lang=en_us&edition=fundamental","pubTime":"2025-03-11 22:33","pubTimestamp":1741703580,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/ENGN/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  March 11, 2025 10:33 ET (14:33 GMT)","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ENGN"],"gpt_icon":0},{"id":"2518530714","title":"enGene Holdings Price Target Maintained With a $25.00/Share by HC Wainwright & Co.","url":"https://stock-news.laohu8.com/highlight/detail?id=2518530714","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2518530714?lang=en_us&edition=fundamental","pubTime":"2025-03-11 18:55","pubTimestamp":1741690500,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/ENGN/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  March 11, 2025 06:55 ET (10:55 GMT)","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ENGN"],"gpt_icon":0},{"id":"2518820017","title":"enGene Holdings Q1 2025 GAAP EPS $(0.48) Misses $(0.39) Estimate","url":"https://stock-news.laohu8.com/highlight/detail?id=2518820017","media":"Benzinga","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2518820017?lang=en_us&edition=fundamental","pubTime":"2025-03-11 04:10","pubTimestamp":1741637413,"startTime":"0","endTime":"0","summary":"enGene Holdings (NASDAQ:ENGN) reported quarterly losses of $(0.48) per share which missed the analyst consensus estimate of $(0.39) by 23.08 percent. This is a 4.35 percent decrease over losses of $(0.46) per share from","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/news/earnings/25/03/44234592/engene-holdings-q1-2025-gaap-eps-0-48-misses-0-39-estimate","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"enGene Holdings Q1 2025 GAAP EPS $(0.48) Misses $(0.39) Estimate","news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ENGN"],"gpt_icon":0},{"id":"2518978200","title":"enGene Holdings Inc Qtrly Loss per Share $0.48","url":"https://stock-news.laohu8.com/highlight/detail?id=2518978200","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2518978200?lang=en_us&edition=fundamental","pubTime":"2025-03-11 04:10","pubTimestamp":1741637410,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250310:nFWN3PT0QZ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","ENGN"],"gpt_icon":0},{"id":"2518200184","title":"Press Release: enGene Reports First Quarter 2025 Financial Results and Provides Business Update","url":"https://stock-news.laohu8.com/highlight/detail?id=2518200184","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2518200184?lang=en_us&edition=fundamental","pubTime":"2025-03-11 04:05","pubTimestamp":1741637100,"startTime":"0","endTime":"0","summary":"Additional preliminary data from ongoing LEGEND study of detalimogene in BCG-unresponsive NMIBC with CIS, including pivotal cohort, anticipated in 2H 2025. Biologics License Application  filing planned for mid-2026 remains on track. Cash and marketable securities of $272.8 million expected to provide runway into 2027. enGene Holdings Inc. , a clinical-stage, non-viral genetic medicines company, today announced its financial results for the first quarter ended January 31, 2025, and provided a business update.LEGEND study now includes maintenance dosing: The amended LEGEND protocol allows patients from all cohorts who are in complete response at 12 months to continue receiving detalimogene on a dose-reduced maintenance schedule throughout their second year of treatment. At the end of year two, patients may elect to remain on maintenance therapy for another year, for a total of three years of therapy. Maintenance treatment consists of two instillations of detalimogene per three-month cycl","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4135","BK4022","BK4232","BK4139","R","BCG","ENGN"],"gpt_icon":0},{"id":"2512410488","title":"New Strong Buy Stocks for February 19th","url":"https://stock-news.laohu8.com/highlight/detail?id=2512410488","media":"Zacks","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2512410488?lang=en_us&edition=fundamental","pubTime":"2025-02-19 18:35","pubTimestamp":1739961300,"startTime":"0","endTime":"0","summary":"Here are five stocks added to the Zacks Rank #1  List today:. GE AerospaceGE: This manufacturer of aircraft engines, components and aircraft mechanical systems has seen the Zacks Consensus Estimate for its current year earnings increasing 3.9% over the last 60 days.Oportun Financial CorporationOPRT: Thisfinancial services provider has seen the Zacks Consensus Estimate for its current year earnings increasing 9.2% over the last 60 days.Oportun Financial Corporation price-consensus-chart | Oportun Financial Corporation Quote. enGene Holdings Inc. ENGN: This clinical-stage biotechnology company has seen the Zacks Consensus Estimate for its current year earnings increasing 8.7% over the last 60 days.Freshworks Inc.FRSH: This software development company has seen the Zacks Consensus Estimate for its current year earnings increasing 6% over the last 60 days.Nova Ltd.NVMI: This semiconductor equipment company has seen the Zacks Consensus Estimate for its current year earnings increasing 5.3% ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/strong-buy-stocks-february-19th-103500247.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["LU2756315318.SGD","LU1366333091.USD","LU0354030511.USD","LU0053671581.USD","SG9999000418.SGD","LU1988902786.USD","LU0149725797.USD","BK4023","FRSH","LU0157215616.USD","LU2264538146.SGD","NVMI","LU0278937759.USD","BK4139","BK4501","GE","LU0820561818.USD","LU1280957306.USD","LU1064131342.USD","LU0820562030.AUD","BK4206","ENGN","BK4166","LU1551013342.USD","BK4585","LU0943347566.SGD","LU2756315664.SGD","BK4187","LU1093756325.SGD","BK4147","LU1261432733.SGD","BK4543","LU0640476718.USD","BK4566","LU0689472784.USD","LU0820561909.HKD","OPRT","LU1093756168.USD","BK4588","LU0868494617.USD","LU0354030438.USD","LU1551013425.SGD"],"gpt_icon":1},{"id":"2512715996","title":"Piper Sandler Initiates Coverage on enGene Holdings With Overweight Rating, $26 Price Target","url":"https://stock-news.laohu8.com/highlight/detail?id=2512715996","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2512715996?lang=en_us&edition=fundamental","pubTime":"2025-02-18 20:10","pubTimestamp":1739880631,"startTime":"0","endTime":"0","summary":"enGene Holdings (ENGN) has an average rating of Buy and mean price target of $25.09, according to analysts polled by FactSet.(MT Newswires covers equity, commodity and economic research from major ban","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["ENGN"],"gpt_icon":0},{"id":"2512158254","title":"enGene Holdings Initiated at Overweight by Piper Sandler","url":"https://stock-news.laohu8.com/highlight/detail?id=2512158254","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2512158254?lang=en_us&edition=fundamental","pubTime":"2025-02-18 19:00","pubTimestamp":1739876400,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/ENGN/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  February 18, 2025 06:00 ET (11:00 GMT)","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ENGN"],"gpt_icon":0},{"id":"2512137338","title":"enGene initiated with an Overweight at Piper Sandler","url":"https://stock-news.laohu8.com/highlight/detail?id=2512137338","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2512137338?lang=en_us&edition=fundamental","pubTime":"2025-02-18 18:05","pubTimestamp":1739873114,"startTime":"0","endTime":"0","summary":"Piper Sandler analyst Allison Bratzel initiated coverage of enGene (ENGN) with an Overweight rating and $26 price target The non-muscle invasive bl...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/engene-initiated-with-an-overweight-at-piper-sandler?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/engene-initiated-with-an-overweight-at-piper-sandler?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","ENGN"],"gpt_icon":0},{"id":"2512137380","title":"Buy Rating for enGene Holdings: Strategic Positioning and Growth Potential in NMIBC Market","url":"https://stock-news.laohu8.com/highlight/detail?id=2512137380","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2512137380?lang=en_us&edition=fundamental","pubTime":"2025-02-18 17:55","pubTimestamp":1739872511,"startTime":"0","endTime":"0","summary":"enGene Holdings (ENGN) has received a new Buy rating, initiated by Piper Sandler analyst, Allison Bratzel. Allison Bratzel has given her Buy rating...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/ratings/buy-rating-for-engene-holdings-strategic-positioning-and-growth-potential-in-nmibc-market?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/ratings/buy-rating-for-engene-holdings-strategic-positioning-and-growth-potential-in-nmibc-market?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","ENGN"],"gpt_icon":0},{"id":"2512907743","title":"enGene Holdings Inc : Piper Sandler Initiates Coverage With Overweight Rating; Price Target $26","url":"https://stock-news.laohu8.com/highlight/detail?id=2512907743","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2512907743?lang=en_us&edition=fundamental","pubTime":"2025-02-18 11:53","pubTimestamp":1739850821,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250218:nFWN3P80F4:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["ENGN","BK4139"],"gpt_icon":0},{"id":"2511612270","title":"Sector Update: Health Care Stocks Decline Late Afternoon","url":"https://stock-news.laohu8.com/highlight/detail?id=2511612270","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2511612270?lang=en_us&edition=fundamental","pubTime":"2025-02-15 04:57","pubTimestamp":1739566675,"startTime":"0","endTime":"0","summary":"Health care stocks were lower late Friday afternoon, with the NYSE Health Care Index and the Health Care Select Sector SPDR Fund  each shedding about 0.9%.The iShares Biotechnology ETF  eased 0.2%.In corporate news, enGene  shares fell past 7% after UBS downgraded the stock to neutral from buy and cut its price target to $7 from $34.Moderna  reported a Q4 loss of $2.91 per share, worse than the $2.83 loss expected in a FactSet poll. Revenue was $966 million, better than the consensus estimate of $942.8 million. Its shares gained about 4%.OS Therapies  shares jumped 12%. The firm said it signed agreements for the commercial-ready manufacturing of OST-HER2 to support anticipated Biologics Licensing Authorization filing.West Pharmaceutical Services  shares popped past 7%.  Deutsche upgraded the stock to buy from hold while lowering its price target to $250 from $275.","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4551","BK4581","MRNA","XLV","WST","IE00BYQQ9H92.USD","BK4568","BK4082","BK4139","OSTX","NPCE","IE00BFXG0V08.USD","BK4534","BK4567","BK4585","BK4533","BK4548","BK4501","ENGN","BK4504","BK4121","BK4532","BK4588","BK4539","IBB","IE00B64QTZ34.USD"],"gpt_icon":1},{"id":"2511611103","title":"enGene Holdings Shares Fall After UBS Downgrade","url":"https://stock-news.laohu8.com/highlight/detail?id=2511611103","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2511611103?lang=en_us&edition=fundamental","pubTime":"2025-02-15 03:54","pubTimestamp":1739562873,"startTime":"0","endTime":"0","summary":"enGene Holdings  shares were down more than 8% in recent Friday trading after UBS downgraded the stock to neutral from buy and cut its price target to $7 from $34.Trading volume stood at over 90,000 shares against a daily average of almost 157,000.Price: 5.73, Change: -0.53, Percent Change: -8.40","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["ENGN"],"gpt_icon":0},{"id":"2511512616","title":"enGene Holdings Cut to Neutral From Buy by UBS","url":"https://stock-news.laohu8.com/highlight/detail?id=2511512616","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2511512616?lang=en_us&edition=fundamental","pubTime":"2025-02-15 02:12","pubTimestamp":1739556720,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/ENGN/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  February 14, 2025 13:12 ET (18:12 GMT)","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ENGN"],"gpt_icon":0},{"id":"2511696512","title":"UBS Downgrades enGene Holdings to Neutral From Buy, Cuts Price Target to $7 From $34","url":"https://stock-news.laohu8.com/highlight/detail?id=2511696512","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2511696512?lang=en_us&edition=fundamental","pubTime":"2025-02-14 22:35","pubTimestamp":1739543712,"startTime":"0","endTime":"0","summary":"enGene Holdings (ENGN) has an average rating of buy and mean price target of $27.70, according to analysts polled by FactSet.(MT Newswires covers equity, commodity and economic research from major ban","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["ENGN"],"gpt_icon":0},{"id":"2511866474","title":"enGene Holdings Inc : UBS Cuts to Neutral From Buy","url":"https://stock-news.laohu8.com/highlight/detail?id=2511866474","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2511866474?lang=en_us&edition=fundamental","pubTime":"2025-02-14 20:21","pubTimestamp":1739535717,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250214:nAZN3D6PFY:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["ENGN","BK4139"],"gpt_icon":0},{"id":"2508600997","title":"enGene Reports Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)","url":"https://stock-news.laohu8.com/highlight/detail?id=2508600997","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2508600997?lang=en_us&edition=fundamental","pubTime":"2025-02-01 05:05","pubTimestamp":1738357500,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250131:nTUAB5F2DD:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","ENGN"],"gpt_icon":0},{"id":"2508997093","title":"enGene Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)","url":"https://stock-news.laohu8.com/highlight/detail?id=2508997093","media":"Business Wire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2508997093?lang=en_us&edition=fundamental","pubTime":"2025-02-01 05:05","pubTimestamp":1738357500,"startTime":"0","endTime":"0","summary":"BOSTON & MONTREAL, January 31, 2025----enGene Holdings Inc. , a clinical-stage genetic medicines company whose non-viral lead investigational product detalimogene voraplasmid, , is in an ongoing pivotal study in patients with high-risk, Bacillus Calmette-Guérin -unresponsive, non-muscle invasive bladder cancer  with carcinoma in situ , today reported the grant of inducement equity awards to seven newly-hired employees, with a grant date of January 29, 2025.The stock options were granted by the Company's independent Compensation Committee of the Board of Directors as an inducement material to each new employee entering into employment with the Company in accordance with NASDAQ Listing Rule 5635. While the stock options were granted outside of the Company’s Amended and Restated enGene Holdings Inc. 2023 Incentive Equity Plan , each option will have terms and conditions consistent with those set forth under the Plan.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/engene-reports-inducement-grants-under-210500992.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["IE00B3QW5Z07.USD","LU2095319765.USD","BK4588","IE00BGHQF748.EUR","IE00B64PRP62.GBP",".IXIC","BK4112","ENGN","LU2210150020.SGD","NDAQ","BK4135","BK4585","IE00BKPKM429.USD","LU2210149790.SGD","BCG","ENGNW"],"gpt_icon":0}],"pageSize":20,"totalPage":3,"pageCount":1,"totalSize":47,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/ENGN\",params:#limit:5,,,undefined,":[{"market":"US","date":"2025-03-10","symbol":"ENGN","fiscalQuarterEnding":"2025/01","expectedEps":-0.37,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1741579200000,"reportTimeType":"post","actualEps":-0.48},{"market":"US","date":"2024-12-19","symbol":"ENGN","fiscalQuarterEnding":"2024/10","expectedEps":-0.4,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1734584400000,"reportTimeType":"post","actualEps":-0.34}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"ENGN\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"ENGN\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.3636,"buy":0.5455,"hold":0.0909,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":0.5455,"analysts":11,"updateTime":1739851200000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/ENGN\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"ENGN","date":"2025-04-23","current":-2.953209,"percent":0.78209,"low":-11.074501,"twenty":-6.747259,"median":-4.379753,"eighty":-2.945826,"high":-1.741293,"avg":-4.791604,"sd":1.940422,"marketCap":203910240},"quantilePoints":[{"date":"2023-11-24","current":-7.107113,"twenty":-7.362609,"median":-7.152095,"eighty":-7.017149,"marketCap":183264010},{"date":"2023-12-01","current":-6.8912,"twenty":-7.362609,"median":-7.170087,"eighty":-7.020748,"marketCap":177696496},{"date":"2023-12-08","current":-6.666292,"twenty":-8.564557,"median":-7.174585,"eighty":-6.887602,"marketCap":171897002},{"date":"2023-12-15","current":-6.641012,"twenty":-7.798032,"median":-7.107113,"eighty":-6.607942,"marketCap":171245139},{"date":"2023-12-22","current":-6.504358,"twenty":-7.362609,"median":-6.814731,"eighty":-6.515153,"marketCap":167721366},{"date":"2023-12-29","current":-7.296036,"twenty":-7.276244,"median":-6.747259,"eighty":-6.432387,"marketCap":188135585},{"date":"2024-01-05","current":-6.405398,"twenty":-7.70447,"median":-6.814731,"eighty":-6.412595,"marketCap":165169589},{"date":"2024-01-12","current":-7.251054,"twenty":-7.438178,"median":-6.882204,"eighty":-6.486365,"marketCap":186975686},{"date":"2024-01-19","current":-7.197076,"twenty":-7.362609,"median":-6.882204,"eighty":-6.515153,"marketCap":185583808},{"date":"2024-01-26","current":-6.837222,"twenty":-7.314029,"median":-6.823728,"eighty":-6.515153,"marketCap":176304617},{"date":"2024-02-02","current":-1.959536,"twenty":-7.276604,"median":-6.810233,"eighty":-6.462974,"marketCap":195790917},{"date":"2024-02-09","current":-1.845771,"twenty":-7.256092,"median":-6.76975,"eighty":-6.369412,"marketCap":184423909},{"date":"2024-02-16","current":-3.645108,"twenty":-7.218667,"median":-6.747259,"eighty":-3.756551,"marketCap":364208223},{"date":"2024-02-23","current":-6.848243,"twenty":-7.197076,"median":-6.729266,"eighty":-3.686899,"marketCap":684255939},{"date":"2024-03-01","current":-6.376994,"twenty":-7.189879,"median":-6.715257,"eighty":-3.782089,"marketCap":637170146},{"date":"2024-03-08","current":-6.913094,"twenty":-7.175485,"median":-6.740159,"eighty":-4.788696,"marketCap":690735636},{"date":"2024-03-15","current":-7.043277,"twenty":-7.155487,"median":-6.747259,"eighty":-6.236267,"marketCap":726936601},{"date":"2024-03-22","current":-7.516207,"twenty":-7.197076,"median":-6.792241,"eighty":-6.288445,"marketCap":775747691},{"date":"2024-03-28","current":-7.279742,"twenty":-7.276523,"median":-6.837222,"eighty":-6.349337,"marketCap":751342146},{"date":"2024-04-05","current":-6.925044,"twenty":-7.26113,"median":-6.876032,"eighty":-6.379076,"marketCap":714733828},{"date":"2024-04-12","current":-6.874373,"twenty":-7.240258,"median":-6.870151,"eighty":-6.391004,"marketCap":709504068},{"date":"2024-04-19","current":-5.983407,"twenty":-7.197076,"median":-6.842733,"eighty":-6.391004,"marketCap":617547460},{"date":"2024-04-26","current":-6.289752,"twenty":-7.193478,"median":-6.810233,"eighty":-6.342947,"marketCap":649165336},{"date":"2024-05-03","current":-6.546128,"twenty":-7.177285,"median":-6.792241,"eighty":-6.351434,"marketCap":675625879},{"date":"2024-05-10","current":-6.153019,"twenty":-7.167527,"median":-6.747259,"eighty":-6.342947,"marketCap":635053046},{"date":"2024-05-17","current":-6.063287,"twenty":-7.153064,"median":-6.743709,"eighty":-6.259918,"marketCap":625791856},{"date":"2024-05-24","current":-5.614629,"twenty":-7.135657,"median":-6.708499,"eighty":-6.098325,"marketCap":579485904},{"date":"2024-05-31","current":-4.486576,"twenty":-7.133587,"median":-6.688278,"eighty":-6.063287,"marketCap":463059513},{"date":"2024-06-07","current":-3.360659,"twenty":-7.131951,"median":-6.661794,"eighty":-5.648813,"marketCap":346853625},{"date":"2024-06-14","current":-4.27293,"twenty":-7.118439,"median":-6.651549,"eighty":-5.484732,"marketCap":441009060},{"date":"2024-06-21","current":-3.406965,"twenty":-7.110292,"median":-6.643683,"eighty":-5.017274,"marketCap":384687244},{"date":"2024-06-28","current":-3.508666,"twenty":-7.107113,"median":-6.634163,"eighty":-4.27293,"marketCap":396170446},{"date":"2024-07-05","current":-3.516489,"twenty":-7.107113,"median":-6.621073,"eighty":-3.815858,"marketCap":397053769},{"date":"2024-07-12","current":-3.5204,"twenty":-7.093203,"median":-6.587237,"eighty":-3.642484,"marketCap":397495431},{"date":"2024-07-15","current":-3.547781,"twenty":-7.089725,"median":-6.572786,"eighty":-3.63199,"marketCap":400587062},{"date":"2024-08-02","current":-3.446081,"twenty":-7.089604,"median":-6.558336,"eighty":-3.589657,"marketCap":389103860},{"date":"2024-08-09","current":-2.777205,"twenty":-7.088397,"median":-6.52142,"eighty":-3.527005,"marketCap":313579728},{"date":"2024-08-16","current":-2.307818,"twenty":-7.080829,"median":-6.504358,"eighty":-3.517271,"marketCap":260580338},{"date":"2024-08-23","current":-2.370403,"twenty":-7.05836,"median":-6.454878,"eighty":-3.458598,"marketCap":267646923},{"date":"2024-08-30","current":-2.573804,"twenty":-7.039722,"median":-6.405398,"eighty":-3.383305,"marketCap":290613326},{"date":"2024-09-06","current":-2.554246,"twenty":-7.025502,"median":-6.379484,"eighty":-3.290156,"marketCap":288405018},{"date":"2024-09-13","current":-2.400727,"twenty":-6.984161,"median":-6.343733,"eighty":-3.031456,"marketCap":293704957},{"date":"2024-09-20","current":-2.587735,"twenty":-6.954602,"median":-6.302571,"eighty":-2.628566,"marketCap":316583531},{"date":"2024-09-27","current":-1.987785,"twenty":-6.936182,"median":-6.238965,"eighty":-2.585538,"marketCap":243185673},{"date":"2024-10-04","current":-2.349201,"twenty":-6.925044,"median":-6.153019,"eighty":-2.573804,"marketCap":287401250},{"date":"2024-10-11","current":-2.479311,"twenty":-6.921741,"median":-6.080379,"eighty":-2.554246,"marketCap":303318858},{"date":"2024-10-18","current":-3.361165,"twenty":-6.921741,"median":-5.983407,"eighty":-2.554246,"marketCap":411204866},{"date":"2024-10-25","current":-3.216598,"twenty":-6.91854,"median":-5.659496,"eighty":-2.56605,"marketCap":393518635},{"date":"2024-10-31","current":-3.137087,"twenty":-6.914183,"median":-5.580446,"eighty":-2.572253,"marketCap":383791208},{"date":"2024-11-08","current":-3.035891,"twenty":-6.895579,"median":-5.443712,"eighty":-2.573804,"marketCap":371410846},{"date":"2024-11-15","current":-3.304095,"twenty":-6.884003,"median":-4.928824,"eighty":-2.580062,"marketCap":404222931},{"date":"2024-11-22","current":-3.195938,"twenty":-6.875939,"median":-4.2302,"eighty":-2.584756,"marketCap":390991104},{"date":"2024-11-29","current":-3.604285,"twenty":-6.87184,"median":-3.830846,"eighty":-2.585538,"marketCap":440948247},{"date":"2024-12-06","current":-3.600118,"twenty":-6.869976,"median":-3.719091,"eighty":-2.585538,"marketCap":440438480},{"date":"2024-12-13","current":-2.745924,"twenty":-6.85689,"median":-3.63199,"eighty":-2.586856,"marketCap":335936294},{"date":"2024-12-20","current":-2.483415,"twenty":-6.84163,"median":-3.604285,"eighty":-2.585538,"marketCap":303820988},{"date":"2024-12-27","current":-5.676196,"twenty":-6.836881,"median":-3.618138,"eighty":-2.585538,"marketCap":312996790},{"date":"2025-01-03","current":-6.526701,"twenty":-6.831143,"median":-3.666853,"eighty":-2.585977,"marketCap":359895332},{"date":"2025-01-10","current":-7.488141,"twenty":-6.86986,"median":-3.752745,"eighty":-2.587735,"marketCap":412911075},{"date":"2025-01-17","current":-6.480478,"twenty":-6.874373,"median":-4.2302,"eighty":-2.598578,"marketCap":357346498},{"date":"2025-01-24","current":-6.739327,"twenty":-6.870995,"median":-4.27293,"eighty":-2.60436,"marketCap":371619968},{"date":"2025-01-31","current":-6.563679,"twenty":-6.869918,"median":-5.380342,"eighty":-2.617897,"marketCap":361934399},{"date":"2025-02-07","current":-5.870333,"twenty":-6.868974,"median":-5.443712,"eighty":-2.624253,"marketCap":323701892},{"date":"2025-02-14","current":-5.777887,"twenty":-6.852345,"median":-5.580446,"eighty":-2.62701,"marketCap":318604225},{"date":"2025-02-21","current":-5.657707,"twenty":-6.84163,"median":-5.580446,"eighty":-2.628136,"marketCap":311977257},{"date":"2025-02-28","current":-5.398857,"twenty":-6.836711,"median":-5.546263,"eighty":-2.689586,"marketCap":297703787},{"date":"2025-03-07","current":-4.908892,"twenty":-6.833612,"median":-5.507012,"eighty":-2.739661,"marketCap":270686149},{"date":"2025-03-14","current":-3.949849,"twenty":-6.818849,"median":-5.443712,"eighty":-2.748264,"marketCap":272725216},{"date":"2025-03-21","current":-3.846555,"twenty":-6.800468,"median":-5.398857,"eighty":-2.766253,"marketCap":265593087},{"date":"2025-03-28","current":-3.506936,"twenty":-6.792928,"median":-5.371072,"eighty":-2.784959,"marketCap":242143410},{"date":"2025-04-04","current":-3.32236,"twenty":-6.792241,"median":-5.209343,"eighty":-2.829161,"marketCap":229399020},{"date":"2025-04-11","current":-2.953209,"twenty":-6.790707,"median":-4.908892,"eighty":-2.913999,"marketCap":203910240},{"date":"2025-04-17","current":-2.923677,"twenty":-6.772715,"median":-4.84418,"eighty":-2.93549,"marketCap":201871137},{"date":"2025-04-23","current":-2.953209,"twenty":-6.747259,"median":-4.379753,"eighty":-2.945826,"marketCap":203910240}],"updateTime":1745524437919}}}